These factors, along with proven efficacy in glycemic control, weight management, and cardiovascular risk reduction, make Europe a key region for the growth and adoption of GLP-1 therapies
With reduced food intake, every bite counts
Glucagon-like peptide-1 cleavage product GLP-1(936) reduces neuroinflammation from stroke via the activation of insulin-like growth factor 1 receptor in astrocytes
Effect of intravenous infusion of exenatide (synthetic exendin-4) on glucose-dependent insulin secretion and counterregulation during hypoglycemia
"We have therefore identified a specific group of nerve cells that is necessary for the effects that semaglutide has on weight and appetite, but which does not appear to contribute to any significant extent to side effects such as nausea." The scientists gave doses of semaglutide to mice and searched for specific brain cells that became active as a consequence
For now, researchers are making decisions based on incomplete but generally encouraging data